Clinical trial Recruiting at 1 site Observational Ages 18 and up

Using active anterior rhinomanometry to guide when surgery is needed for nasal obstruction.

Official title: Evaluation of the Reliability of Anterior Active Rhinomanometry as an Independent Tool for Surgical Indication in Nasal Obstruction

Run by Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer · NCT07379775 · Data updated 2026-11-12

This test will try whether preoperative rhinomanometry can help decide if adults with nasal obstruction should have septoplasty, turbinate reduction, or rhinoplasty.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorCentre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Academic / other
Locations1 site (Draguignan, Var)
StatusRecruiting
StartedJanuary 27, 2026
Main results expectedJanuary 2028
Study endsMarch 2028
Registry record updatedJuly 7, 2026
Trial IDNCT07379775 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18 years) with nasal obstruction who are already scheduled for septoplasty, turbinate reduction, or rhinoplasty and who had preoperative rhinomanometry and consent to participate.

Probably not a fit

Patients with nasal polyps, chronic edematous or crusting rhinosinusitis, or current/past sinonasal tumors — who are excluded from this protocol — are unlikely to benefit from AAR as tested here.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study collects preoperative active anterior rhinomanometry (AAR) measurements in adults scheduled for surgical correction of nasal obstruction to determine whether AAR can independently indicate the need for surgery. Participants are adults with nasal obstruction who underwent rhinomanometry and are scheduled for septoplasty ± turbinoplasty ± rhinoplasty; patients with nasal polyps, certain chronic rhinosinusitis forms, or sinonasal tumors are excluded. Investigators will compare AAR results with clinical findings and standard patient-reported outcome scores (for example VAS, NOSE, SNOT-22) to judge whether AAR alone reliably identifies surgical candidates. The protocol is conducted at a regional hospital in Draguignan, France.

Why it matters

Potential benefit: If successful, this could give doctors a simple objective test to standardize surgical decisions and reduce unnecessary or ineffective nasal surgeries.

How similar studies have gone: Rhinomanometry is a well-established objective measure used alongside symptoms and imaging, but relying on it alone as the sole indication for surgery is not widely validated in prior work.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients aged 18 years or older with nasal obstruction (NO).
2. Patients scheduled for surgery: septoplasty ± turbinoplasty ± rhinoplasty for nasal obstruction.
3. Patients who have undergone a preoperative rhinomanometry assessment.
4. Patients consented to participation

Exclusion Criteria:

1. Nasal polyps.
2. Chronic edematous-purulent rhinosinusitis (e.g., cystic fibrosis).
3. Crusting rhinosinusitis (e.g., sarcoidosis, granulomatosis with polyangiitis \[Wegener's\]).
4. Current or previously treated nasal or sinus tumors, or patients undergoing tumor work-up

Where it's running

  • Centre Hospitalier de la Dracénie
    Draguignan, Var, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.